🎉 Announcing our initiative with MSK

Dear all,

Today marks an important milestone in our journey.

Our mission is to make AI accessible to scientist and physician end-users who can most realize its potential and ultimately better serve patients. And we are thrilled to announce we are one step closer to making a real-world impact under an initiative with Memorial Sloan Kettering Cancer Center (MSK).

In this initiative, our platform will be used to deploy cutting-edge NLP tools for EHR analysis and data collection, making them accessible to clinicians evaluating drug efficacy in clinical trials.

Read more in the release here.

Do you want to learn about how we help organizations commercialize AI tools? Simply reply to this email and we can find a time to chat.

We can’t wait to share all the other exciting things we are working on. More to come, very soon!

Best,
Superbio AI
P.S. - Want to learn about more of Superbio’s work?
Check out our blog here.